IMMUNO-COV Trademark

Trademark Overview

On Thursday, May 7, 2020, a trademark application was filed for IMMUNO-COV with the United States Patent and Trademark Office. The USPTO has given the IMMUNO-COV trademark a serial number of 88906096. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The IMMUNO-COV trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples
immuno-cov

General Information

Serial Number88906096
Word MarkIMMUNO-COV
Filing DateThursday, May 7, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU EXTENSION 5 GRANTED
Tuesday, April 4, 2023SOU EXTENSION 5 FILED
Wednesday, April 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2022SOU EXTENSION 4 GRANTED
Friday, October 28, 2022SOU EXTENSION 4 FILED
Friday, October 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 3 GRANTED
Monday, May 2, 2022SOU EXTENSION 3 FILED
Monday, May 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 14, 2021SOU EXTENSION 2 GRANTED
Thursday, October 14, 2021SOU EXTENSION 2 FILED
Thursday, October 14, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 1 GRANTED
Thursday, April 15, 2021SOU EXTENSION 1 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 27, 2020ASSIGNED TO EXAMINER
Wednesday, May 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 11, 2020NEW APPLICATION ENTERED

Related Keywords

immuno diagnostic antibodies identifying namely neutralize sars samples blood patient virus